Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Insmed
INSM
$21.4B
| $1.92M | ﹤0.01% |
90,862
-157,129
| -63% | -$2.98M |
|
3452
PUT
West Pharmaceutical
WST
$24B
| $1.91M | ﹤0.01% |
5,000
+2,000
| +67% | +$714K |
|
3453
PUT
Shake Shack
SHAK
$2.53B
| $1.91M | ﹤0.01% |
+24,600
| New | +$1.58M |
|
3454
Camping World
CWH
$639M
| $1.91M | ﹤0.01% |
63,461
-845,304
| -93% | -$21.3M |
|
3455
Philips
PHG
$25.7B
| $1.91M | ﹤0.01% |
+98,415
| New | +$1.72M |
|
3456
Nabors Industries
NBR
$1.27B
| $1.91M | ﹤0.01% |
20,517
-92,940
| -82% | -$9.45M |
|
3457
AtaiBeckley Inc
ATAI
$2.66B
| $1.91M | ﹤0.01% |
1,108,145
+374,334
| +51% | +$689K |
|
3458
Essent Group
ESNT
$6.08B
| $1.9M | ﹤0.01% |
+40,692
| New | +$1.77M |
|
|
AFMD
3459
DELISTED
Affimed
AFMD
| $1.9M | ﹤0.01% |
317,746
+143,530
| +82% | +$1.15M |
|
|
GAMB
3460
DELISTED
Gambling.com
GAMB
| $1.9M | ﹤0.01% |
185,573
+150,377
| +427% | +$1.51M |
|
3461
Fulcrum Therapeutics
FULC
$273M
| $1.9M | ﹤0.01% |
574,857
-45,702
| -7% | -$134K |
|
3462
Adicet Bio
ACET
$85.2M
| $1.89M | ﹤0.01% |
48,730
+38,050
| +356% | +$3.36M |
|
3463
IAMGOLD
IAG
$8.2B
| $1.89M | ﹤0.01% |
718,608
-4,215,860
| -85% | -$12.2M |
|
3464
Abercrombie & Fitch
ANF
$4.42B
| $1.89M | ﹤0.01% |
50,117
-973,309
| -95% | -$27.7M |
|
|
IMGN
3465
CALL
DELISTED
Immunogen Inc
IMGN
| $1.89M | ﹤0.01% |
100,000
-544,500
| -84% | -$6.43M |
|
3466
CALL
Establishment Labs
ESTA
$2.72B
| $1.89M | ﹤0.01% |
27,500
-2,500
| -8% | -$173K |
|
3467
CALL
Cognizant
CTSH
$24.9B
| $1.89M | ﹤0.01% |
28,900
-162,300
| -85% | -$10.1M |
|
3468
Omeros
OMER
$857M
| $1.88M | ﹤0.01% |
345,864
+11,529
| +3% | +$67.3K |
|
|
PLL
3469
PUT
DELISTED
Piedmont Lithium
PLL
| $1.88M | ﹤0.01% |
+32,600
| New | +$1.87M |
|
3470
PUT
State Street
STT
$50.6B
| $1.88M | ﹤0.01% |
+25,700
| New | +$1.85M |
|
3471
KALA BIO
KALA
$14.1M
| $1.88M | ﹤0.01% |
2,577
-292
| -10% | -$227K |
|
3472
PUT
AGNC Investment
AGNC
$12.4B
| $1.88M | ﹤0.01% |
185,400
| – | – |
|
3473
AXT Inc
AXTI
$3.95B
| $1.88M | ﹤0.01% |
545,288
+519,349
| +2,002% | +$1.75M |
|
3474
CALL
Teradyne
TER
$57.6B
| $1.87M | ﹤0.01% |
16,800
-41,700
| -71% | -$4.18M |
|
|
SRDX
3475
PUT
DELISTED
Surmodics
SRDX
| $1.87M | ﹤0.01% |
+59,600
| New | +$1.36M |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.